Judith Eve Kingston (24 April 1949 – 24 January 2016) was an English paediatric oncologist best known for pioneering the use of chemotherapy in the treatment of the retinoblastoma form of cancer.
[1] She studied biochemistry and then medicine at Bristol University,[2] receiving a BSc in 1970 and an MB ChB in 1973.
[2] Kingston worked at the University of Oxford as a clinical research fellow from 1980 to 1983.
[1] In 1983, she was appointed honorary consultant and senior lecturer at St Bartholomew's Hospital in London.
She pioneered the use of chemotherapy as a first-line treatment for children with retinoblastoma; her collaborator John Hungerford, an ophthalmologist, wrote that "The world of expertise in retinoblastoma is totally agreed that Judith's contribution has been paramount to the current world wide treatment of this tumour in thousands of children worldwide.